Alphabet Inc’s Dianthus Therapeutics DNTH Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.89M	Hold	208,697	–	–	0.18%	20
2025 Q1	$3.79M	Hold	208,697	–	–	0.24%	22
2024 Q4	$4.55M	Hold	208,697	–	–	0.26%	18
2024 Q3	$5.71M	Hold	208,697	–	–	0.31%	20
2024 Q2	$5.4M	Hold	208,697	–	–	0.27%	22
2024 Q1	$6.26M	Hold	208,697	–	–	0.25%	23
2023 Q4	$2.17M	Hold	208,697	–	–	0.1%	30
2023 Q3	$2.85M	Sell	208,697 -3,130,441	-94%	-$42.8M	0.18%	25
2023 Q2	$2.54M	Hold	3,339,138	–	–	0.14%	30
2023 Q1	$2.64M	Hold	3,339,138	–	–	0.15%	29
2022 Q4	$1.34M	Hold	3,339,138	–	–	0.08%	42
2022 Q3	$4.71M	Hold	3,339,138	–	–	0.24%	32
2022 Q2	$4.01M	Hold	3,339,138	–	–	0.22%	36
2022 Q1	$9.68M	Hold	3,339,138	–	–	0.31%	30
2021 Q4	$14.8M	Hold	3,339,138	–	–	0.36%	32
2021 Q3	$24.3M	Hold	3,339,138	–	–	0.58%	19
2021 Q2	$32.7M	Hold	3,339,138	–	–	0.67%	17
2021 Q1	$39.5M	Hold	3,339,138	–	–	1.59%	13
2020 Q4	$26.2M	Hold	3,339,138	–	–	1.26%	14
2020 Q3	$22.7M	Hold	3,339,138	–	–	1.07%	9
2020 Q2	$25.1M	Hold	3,339,138	–	–	1.16%	8
2020 Q1	$21M	Hold	3,339,138	–	–	1.38%	8
2019 Q4	$50.6M	Hold	3,339,138	–	–	3.06%	6
2019 Q3	$34.3M	Hold	3,339,138	–	–	1.03%	5
2019 Q2	$49.3M	Hold	3,339,138	–	–	0.93%	5
2019 Q1	$55M	Hold	3,339,138	–	–	2.84%	5
2018 Q4	$19M	Hold	3,339,138	–	–	2.25%	9
2018 Q3	$40.1M	Hold	3,339,138	–	–	3.84%	7
2018 Q2	$45.1M	Buy	+3,339,138	New	+$45.1M	3.79%	6